January 10, 2022Clinical Kidney JournalOpen Access

Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data

View Full Paper

Ask AI

Bookmark

Abstract

Stopping RASi use among survivors of moderate-to-severe AKI was associated with a similar risk of recurrent AKI, but higher risk of the composite of death, MI and stroke.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Janse et al. (2022) studied this question.

synapsesocial.com/papers/69dca7c84006ebb8efe52ec2 https://doi.org/10.1093/ckj/sfac003

View Full Paper

Ask AI

Bookmark

Abstract

Stopping RASi use among survivors of moderate-to-severe AKI was associated with a similar risk of recurrent AKI, but higher risk of the composite of death, MI and stroke.

Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data

Abstract

Discussion

Cite This Study

Stopping versus continuing renin–angiotensin–system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data

Abstract

Discussion

Cite This Study

Keep reading

Keep reading